Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-RTN4R/NgR1/Nogor Antibody (M5)

Catalog #:   RHK98201 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG1
Applications: ELISA, FCM, IF, IP, SPR, WB
Accession: Q9BZR6
Overview

Catalog No.

RHK98201

Species reactivity

Human

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

NgR, Nogo receptor, Reticulon-4 receptor, RTN4R, Nogo-66 receptor, NOGOR

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9BZR6

Applications

ELISA, FCM, IF, IP, SPR, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

M5

Data Image
References

Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis., PMID:36597597

An in-depth analysis reveals two new genetic variants on 22q11.2 associated with vitiligo in the Chinese Han population., PMID:34350550

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF., PMID:33536561

Identification of a new functional domain of Nogo-A that promotes inflammatory pain and inhibits neurite growth through binding to NgR1., PMID:32598099

Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B., PMID:32201946

Nogo receptor 1 is expressed by nearly all retinal ganglion cells., PMID:29768445

The Subventricular Zone Response to Stroke Is Not a Therapeutic Target of Anti-Nogo-A Immunotherapy., PMID:28789474

Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells., PMID:27076679

Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis., PMID:25437093

Anti-Nogo-A antibody: a treatment option for neurogenic lower urinary tract dysfunction?, PMID:25430943

Therapeutics targeting Nogo-A hold promise for stroke restoration., PMID:23394537

Changes in expression of Nogo receptor 1 in hippocampus and cortex after cardiopulmonary resuscitation in rats., PMID:23158614

PirB restricts neuronal regeneration in developing rat brain following hypoxia-ischemia., PMID:22580685

Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation., PMID:22544872

The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord., PMID:22236767

Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells., PMID:22227458

Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro., PMID:22145612

Soluble Nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma., PMID:21948553

The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats., PMID:21784510

Targeting the Nogo receptor complex in diseases of the central nervous system., PMID:21110803

Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury., PMID:20725955

Effect of combined treatment with methylprednisolone and Nogo-A monoclonal antibody after rat spinal cord injury., PMID:20515570

Neurites regrowth of cortical neurons by GSK3beta inhibition independently of Nogo receptor 1., PMID:20374426

Localization of an axon growth inhibitory molecule Nogo and its receptor in the spinal cord of mouse embryos., PMID:19833111

Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold., PMID:19530168

PirB is a functional receptor for myelin inhibitors of axonal regeneration., PMID:18988857

Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats., PMID:18930141

An experimental test of stroke recovery by implanting a hyaluronic acid hydrogel carrying a Nogo receptor antibody in a rat model., PMID:18458480

An immunofluorescence-histochemistry study of the Nogo receptor in the rat retina during postnatal development., PMID:17984503

[NgR expression in oligodendrocyte precursor cells and its changes after oxygen & glucose deprivation in neonatal rats]., PMID:17937855

Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration., PMID:17488779

Epitope mapping of the neuronal growth inhibitor Nogo-A for the Nogo receptor and the cognate monoclonal antibody IN-1 by means of the SPOT technique., PMID:17486692

Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells., PMID:17428512

DNA vaccine against NgR promotes functional recovery after spinal cord injury in adult rats., PMID:17362886

Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls., PMID:17295709

Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease., PMID:17188332

Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector., PMID:17140598

[Preparation and identification of rabbit antibody against LRR of Nogo-66 receptor (NgR)]., PMID:16948913

Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat., PMID:16321384

The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro., PMID:16298084

Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury., PMID:16101740

Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?, PMID:16092935

Nogo-66 receptor at cerebellar cortical glia gap junctions in the rat., PMID:16088223

Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display., PMID:16061255

Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitro., PMID:15653130

Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells., PMID:15312170

Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions., PMID:15121177

Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions., PMID:12843238

Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth., PMID:12160746

Nogo-66 receptor antagonist peptide promotes axonal regeneration., PMID:12037567

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-RTN4R/NgR1/Nogor Antibody (M5) [RHK98201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only